Clinical Trials
India’s 1st COVID-19 Vaccine -COVAXIN, Developed by Bharat Biotech gets DCGI approval for Phase I & II Human Clinical Trials
Bharat Biotech has successfully developed COVAXIN™, India’s 1stvaccine candidate for COVID-19, in collaboration with the Indian Council of Medical Research (ICMR) -National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech....
Press Releases
Bormioli Pharma invests in Type I glass vial production for injectable medicines and vaccines
The company invested more than 50 million euros in the last months for improving its production platform, including a brand-new glass furnace in Bergantino, the upgrade of the San Vito al Tagliamento glass production, as well as the acquisition...
Drug Research
Stevanato Group signs an agreement with the CEPI to provide pharma glass vials for 2 billion doses of COVID-19 vaccines under development
Italy-based Stevanato Group, a leading producer of pharmaceutical glass containers and integrated provider of drug delivery systems, and CEPI (the Coalition for Epidemic Preparedness Innovations) - the global partnership at the forefront of funding and coordinating the development of...
Clinical Trials
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an effective immune response against Covid-19.
The trial will recruit 300 healthy participants who will then receive...
Clinical Trials
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19 in a Phase III study.
Indianapolis-based Eli Lilly said the latest study will complement an ongoing study of the rheumatoid arthritis drug being conducted in...
Articles
Creating your Secondary Packaging Strategy
When to Start Creating Your Secondary Packaging Strategy
Pharmaceutical and biotechnology companies with a drug product in clinical development are usually focused on a quick commercial launch. Secondary packaging aspects are often less considered. Correlations with secondary packaging (in this...
Clinical Trials
Greenphire Enhances Its Participant Payment and Reimbursement Solution to Further Support Remote Clinical Trials
As the COVID-19 pandemic continues to limit movement all over the world, clinical trials have had to adapt by leveraging methodologies typically associated with hybrid or remote clinical trial designs. The alternative would be to suspend the trial and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
